N/A
Completed N=112
Co-Use of Opioid Medications and Alcohol Prevention Study
Alcohol Drinking · Opioid Use Disorder
Source: ClinicalTrials.gov NCT05599672 ↗
Enrolled (actual)
112
Serious AEs
—
Results posted
Sep 2025
Primary outcomePrimary: Alcohol Use Reductions — 11; 12; 1; 1 Participants
Summary
Previous research, including that of this team, shows that a significant portion of those regularly using opioids-particularly filling opioids at community pharmacies-also are involved in the co-use of alcohol. This study proposes to adapt a previously developed intervention for opioid medication misuse; test its acceptability, feasibility, and preliminary efficacy; and identify barriers and facilitators to large-scale research and system-level implementation. Results of this study will directly inform a fully-powered subsequent multisite trial.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Alcohol Use Reductions |
11; 12; 1; 1; 1; 2 | — |
| PRIMARY Opioid Medication Use |
12; 17; 1; 0; 1; 0 | — |
Eligibility Criteria
Inclusion Criteria
- English speaking
- ≥18 years
- Not receiving cancer treatment
- Current alcohol use
- Prescribed an opioid medication
Exclusion Criteria
- SA 2 exclusion
- Are pregnant
- Cannot provide collateral contact information for ≥2 persons
- Do not have a reliable land line or mobile phone to be contacted by study staff
- Are filling only buprenorphine
- Plan to leave the area for an extended period of time in the next 3-months, or
- Have experienced a psychotic and/or manic episode in the last 30 days
Data sourced from ClinicalTrials.gov (NCT05599672). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.